Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients

Dr. John Fleetham sits down with Drs. David Lipson and Jorgen Vestbo to discuss the article "Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients".

Show Notes

The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

What is Out of the Blue: An AJRCCM Podcast?

The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.